Systematic reviews as a tool for planning and interpreting trials [PDF]
, 2009 Background Systematic reviews followed by ameta-analysis are carried out in medical research to combine the results of two or more related studies. Stroke trials have struggled to show beneficial effects and meta-analysis should be used more widely ...
Bath, Philip M.W., Gray, Laura J.
core
Case Reports in Neurology, 2011 Background: Acute ischemia typically results in a flaccid paralysis. An immediate spastic hemiparesis following ischemia has rarely been reported.
Jordan Dubow +2 more
doaj +1 more source
Prediction of myocardial infarction size using the SYNTAX score in patients treated with primary percutaneous coronary intervention for acute ST- segment elevation myocardial infarction [PDF]
, 2012 Objectives The relevance of the SYNTAX score for the particular case of patients with acute ST- segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) has previously only been studied in the setting ...
Daellenbach, J.
core
Letter by Abdellaoui et al Regarding Article, “Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention” [PDF]
, 2009 M. Abdellaoui +2 more
openalex +1 more source
Primary Coronary Angioplasty in the Elderly [PDF]
, 2005 Introdução: A angioplastia primária é a terapêutica de reperfusão com melhores resultados no enfarte agudo do miocárdio (EAM). Este facto assume particular relevância na população acima dos 75 anos, em que o risco hemorrágico relacionado com a trombólise
Cacela, D +8 more
core
Terapias emergentes: inhibidores de glicoproteína IIB/IIIA en ataque cerebrovascular agudo
Acta Neurológica Colombiana, 2010 El ataque cerebrovascular (ACV) es una causa común de morbilidad y mortalidad en el mundo. La terapia trom- bolítica con (r-TPA), es la única terapia aprobada para el tratamiento del ACV y esta terapia solo se logra aplicar en el 2 % de los pacientes ...
Juliana Coral Casas
doaj +2 more sources
Heart Views, 2013 Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration.
Mohammed Balghith +3 more
doaj
Fatal Hemorrhagic Transformation of Acute Cerebral Infarction After the Use of Abciximab [PDF]
, 2000 Raymond T.F. Cheung, David S.W. Ho
openalex +1 more source
Delayed Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy [PDF]
, 1998 Leigh Ann Jenkins +3 more
openalex +1 more source
Platelet Inhibition in Percutaneous Coronary Interventions [PDF]
, 2018 : Mechanical disruption of atherosclerotic plaques at the time of percutaneous coronary intervention (PCI) is a potent stimulus for arterial thrombosis.
Roffi, Marco, Wyss, Christophe
core